Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 717 (USA) (Dr. Reyes)
· consented 2013-12-19
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild ALOPECIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-15 (study day 28.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-19 (study day 1.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.